ImmuCell appoints Timothy C. Fiori as CFO effective April 7, 2025

IMMUCELL CORP /DE/

Fiori served 24 years at IDEXX Laboratories, most recently as Senior Director Finance, Commercial Operations.
Annual base salary set at $250,000; eligible for company benefit plans and 2017 Stock Option and Incentive Plan.
Incentive Compensation Agreement provides cash bonuses tied to attainment of specific objectives.
Press release dated April 7, 2025 furnished as Exhibit 99.1.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Timothy C. Fiori

Chief Financial Officer

ICCC · IMMUCELL CORP /DE/

Effective: 2025-04-07
Filed: April 7, 2025, 7:59 PM ET

The Board of Directors of ImmuCell Corporation (the Company) has elected Timothy C. Fiori, age 46, to serve as its Chief Financial Officer effective April 7, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy C. Fiori was elected as Chief Financial Officer at IMMUCELL CORP /DE/.

Action: elected
Role: Chief Financial Officer

Exact text from the filing

The Board of Directors of ImmuCell Corporation (the Company) has elected Timothy C. Fiori, age 46, to serve as its Chief Financial Officer effective April 7, 2025.

View on SEC.gov

IMMUCELL CORP /DE/ filing history →

Source: SEC EDGAR

accession 0001213900-25-029407

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.